Indication
Intrinsic Pontine Glioma
1 clinical trial
1 product
Clinical trial
A Phase 2 Study of Atengenal (A-10) and Astugenal (AS2-1) in Diffuse, Intrinsic Pontine Glioma (DIPG)Status: , Estimated PCD: 2028-03-01
Product
Antineoplaston therapy1 clinical trial
1 product